Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SINTILIMAB vs SIROLIMUS: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SINTILIMAB vs SIROLIMUS: Safety Overview

Metric SINTILIMAB SIROLIMUS
Total FAERS Reports 652 11,371
Deaths Reported 61 1,737
Death Rate 9.4% 15.3%
Hospitalizations 225 3,535
Average Patient Age 57.6 yrs 43.1 yrs
% Female Patients 35.0% 45.4%
FDA Approval Date N/A Aug 22, 2002
Manufacturer N/A Zydus Lifesciences Limited
Route N/A ORAL
Marketing Status N/A Prescription